Eurofins-Cerep SA (EPA:ALECR)
France · Delayed Price · Currency is EUR 16,800
0.00 (0.00%)
At close: Nov 28, 2025
Eurofins-Cerep Company Description
Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally.
The company’s research services include compound management, and high-throughput screening and profiling.
The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014. Eurofins-Cerep SA was founded in 1989 and is based in Celle-Lévescault, France.
Eurofins-Cerep SA is a subsidiary of Eurofins Discovery Services LUX Holding SARL.
Eurofins-Cerep SA
| Country | France |
| Founded | 1989 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 207 |
| CEO | Damien Vielliard |
Contact Details
Address: 2 rue du professeur GargouIl Celle-Lévescault, Ile-de-France 86600 France | |
| Phone | 33 5 49 89 30 00 |
| Website | eurofins.fr |
Stock Details
| Ticker Symbol | ALECR |
| Exchange | Euronext Paris |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | FR0013256518 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Damien Vielliard | Chief Executive Officer and Director |
| Sophie Macault | General Counsel and Corporate Secretary |